Swiss neonatal network | Vermont-oxford-network | EuroNeoNet | Difference VON-SNN | |||
---|---|---|---|---|---|---|
All units | min. | max. | ||||
Years | 2009-2011 | 2009 | 2011 | 2010 | 2010 | - |
Units | 9 | - | - | ca. 850 | 96 | - |
N | 2025 | 95 | 388 | 53862 | 6389 | - |
Sex male | 52.2% | 42.3% | 59.8% | 51.0% | 50.4% | 0.29 |
Multiples | 36.0% | 24.9% | 44.2% | 28.0% | 33.1% | <0.001 |
Small for Gestation | 19.2% | 15.4% | 21.4% | 21.0% | 0.05 | |
Inborn | 95.0% | 91.5% | 97.8% | 86.0% | <0.001 | |
UapH measured | 82.7% | *64.4% | *94.7% | |||
Caesarean Section | 77.2% | *63.4% | *88.5% | 73.0% | 72.3% | <0.001 |
Full prenatal steroids | 71.1% | *59.8% | *79.8% | |||
Any prenatal steroids | 87.9% | 79.7% | *98.6% | 78.0% | 83.5% | <0.001 |
Major birth defects | 5.0% | 3.4% | 7.0% | 5.0% | 1 | |
Mortality | 13.6% | 5.8% | *19.4% | 12.6% | 10.8% | 0.185 |
PDA† | 28.3% | *11.2% | *41.8% | 37.0% | <0.001 | |
PPH† | 5.4% | *0.9% | *12.4% | |||
NEC† | 2.0% | 0.6% | 3.6% | 6.0% | 5.9% | <0.001 |
Early Onset Sepsis† | 2.0% | 0.6% | *7.4% | 2.0% | 3.5% | 1 |
Late Onset Sepsis† | 7.4% | 2.5% | *11.7% | 15.0% | 25.5% | <0.001 |
O2 at 36w GA‡ | 9.5% | 3.0% | 19.8% | 30.0% | 10.7% | <0.001 |
Mechanical ventilation† | 51.8% | *40.6% | *71.5% | 64.0% | <0.001 | |
CPAP† | 78.4% | *67.3% | *86.3% | 69.0% | <0.001 | |
CPAP w/o mech. vent.† | 31.3% | *12.6% | *47.6% | |||
Surfactant† | 45.9% | *25.1% | *65.2% | 64.0% | 51.8% | <0.001 |
ROP stage 3-4† | 2.3% | 0.0% | 5.3% | 6.0% | 2.7% | <0.001 |
PIH stage 3-4† | 6.4% | 3.8% | 9.8% | 9.0% | 7.7% | <0.001 |
cPVL† | 2.3% | 0.0% | 4.7% | 3.2% | 3.9% | 0.027 |
Growth† | 9.4% | *7.7% | *14.5% | |||
Surgery† | 10.3% | 5.0% | 15.2% | 16.0% | <0.001 | |
Length of stay† | 56.9 | 46.9 | 65.2 | |||
Length of stay‡ | 55.0 | 44.2 | 64.4 | 64.8 | n/a |